G0S2 抗体 (AA 1-103)
Quick Overview for G0S2 抗体 (AA 1-103) (ABIN1734528)
抗原
See all G0S2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-103
- 
                                            特异性
- Reacts with human GOS2 protein
- 
                                            纯化方法
- Purified
- 
                                            免疫原
- A genomic peptide made to the human G0S2 protein (residues 1-103). [Swiss-Prot P27469]
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Working dilution: Optimal dilution should be determined by the end user. 
 The following are guidelines only :
 - ICC : 1/50 to 1/100 - IF : 1/50 to 1/100
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- PBS, glycerol 50 % , BSA 0.1 %, Sodium azide 0.05 %
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C/-20 °C
- 
                                            储存方法
- Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- 
                                            有效期
- 6 months
 
- 
                                            
- 
    - G0S2 (G0/G1switch 2 (G0S2))
- 
                                            别名
- G0/G1 Switch Protein 2
- 
                                            途径
- Regulation of Lipid Metabolism by PPARalpha
 抗原
- 
                    
 
                                     
                                     
                                    